Literature DB >> 24976619

Association of central serotonin transporter availability and body mass index in healthy Europeans.

Swen Hesse1, Elsmarieke van de Giessen2, Franziska Zientek3, David Petroff4, Karsten Winter5, John C Dickson6, Livia Tossici-Bolt7, Terez Sera8, Susanne Asenbaum9, Jacques Darcourt10, Umit O Akdemir11, Gitte M Knudsen12, Flavio Nobili13, Marco Pagani14, Thierry Vander Borght15, Koen Van Laere16, Andrea Varrone17, Klaus Tatsch18, Osama Sabri19, Jan Booij2.   

Abstract

UNLABELLED: Serotonin-mediated mechanisms, in particular via the serotonin transporter (SERT), are thought to have an effect on food intake and play an important role in the pathophysiology of obesity. However, imaging studies that examined the correlation between body mass index (BMI) and SERT are sparse and provided contradictory results. The aim of this study was to further test the association between SERT and BMI in a large cohort of healthy subjects.
METHODS: 127 subjects of the ENC DAT database (58 females, age 52 ± 18 years, range 20-83, BMI 25.2 ± 3.8 kg/m(2), range 18.2-41.1) were analysed using region-of-interest (ROI) and voxel-based approaches to calculate [(123)I]FP-CIT specific-to-nonspecific binding ratios (SBR) in the hypothalamus/thalamus and midbrain/brainstem as SERT-specific target regions.
RESULTS: In the voxel-based analysis, SERT availability and BMI were positively associated in the thalamus, but not in the midbrain. In the ROI-analysis, the interaction between gender and BMI showed a trend with higher correlation coefficient for men in the midbrain albeit not significant (0.033SBRm(2)/kg, p=0.1).
CONCLUSIONS: The data are in agreement with previous PET findings of an altered central serotonergic tone depending on BMI, as a probable pathophysiologic mechanism in obesity, and should encourage further clinical studies in obesity targeting the serotonergic system.
Copyright © 2014 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Keywords:  5-HTT; BMI; FP-CIT; Obesity; SPECT; Serotonin

Mesh:

Substances:

Year:  2014        PMID: 24976619     DOI: 10.1016/j.euroneuro.2014.05.005

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  15 in total

1.  Sex differences in serotonin-hypothalamic connections underpin a diminished sense of emotional well-being with increasing body weight.

Authors:  J Melasch; M Rullmann; A Hilbert; J Luthardt; G A Becker; M Patt; M Stumvoll; M Blüher; A Villringer; K Arelin; P M Meyer; A Bresch; O Sabri; S Hesse; B Pleger
Journal:  Int J Obes (Lond)       Date:  2016-04-22       Impact factor: 5.095

2.  The Role of the Serotonergic System in REM Sleep Behavior Disorder.

Authors:  Dario Arnaldi; Francesco Famà; Fabrizio De Carli; Silvia Morbelli; Michela Ferrara; Agnese Picco; Jennifer Accardo; Alberto Primavera; Gianmario Sambuceti; Flavio Nobili
Journal:  Sleep       Date:  2015-09-01       Impact factor: 5.849

3.  False positive rates in positron emission tomography (PET) voxelwise analyses.

Authors:  Melanie Ganz; Martin Nørgaard; Vincent Beliveau; Claus Svarer; Gitte M Knudsen; Douglas N Greve
Journal:  J Cereb Blood Flow Metab       Date:  2020-11-26       Impact factor: 6.200

4.  Serotonin transporter is negatively associated with body mass index after glucose loading in humans.

Authors:  Kyoungjune Pak; Keunyoung Kim; Seongho Seo; Myung Jun Lee; In Joo Kim
Journal:  Brain Imaging Behav       Date:  2022-01-03       Impact factor: 3.978

Review 5.  Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review.

Authors:  Manoj K Mahapatra; Muthukumar Karuppasamy; Biswa M Sahoo
Journal:  Pharm Res       Date:  2022-06-01       Impact factor: 4.580

6.  Reduced serotonin receptors and transporters in normal aging adults: a meta-analysis of PET and SPECT imaging studies.

Authors:  Teresa M Karrer; Casey L McLaughlin; Carmela P Guaglianone; Gregory R Samanez-Larkin
Journal:  Neurobiol Aging       Date:  2019-04-05       Impact factor: 4.673

7.  Central serotonin transporter availability in highly obese individuals compared with non-obese controls: A [(11)C] DASB positron emission tomography study.

Authors:  Swen Hesse; Michael Rullmann; Julia Luthardt; Karsten Winter; Mohammed K Hankir; Georg-Alexander Becker; Franziska Zientek; Georg Reissig; Ralf Regenthal; Mandy Drabe; Christian Schinke; Anke Bresch; Katrin Arelin; Donald Lobsien; Marianne Patt; Philipp M Meyer; Mathias Fasshauer; Wiebke K Fenske; Matthias Blüher; Michael Stumvoll; Osama Sabri
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-18       Impact factor: 9.236

Review 8.  Lesser Investigated Natural Ingredients for the Management of Obesity.

Authors:  Muhammed Majeed; Shaheen Majeed; Kalyanam Nagabhushanam; Muthuraman Gnanamani; Lakshmi Mundkur
Journal:  Nutrients       Date:  2021-02-04       Impact factor: 5.717

9.  Dissociable Effects of Serotonin and Dopamine on the Valuation of Harm in Moral Decision Making.

Authors:  Molly J Crockett; Jenifer Z Siegel; Zeb Kurth-Nelson; Olga T Ousdal; Giles Story; Carolyn Frieband; Johanna M Grosse-Rueskamp; Peter Dayan; Raymond J Dolan
Journal:  Curr Biol       Date:  2015-07-02       Impact factor: 10.834

10.  The Effect of Obesity on the Availabilities of Dopamine and Serotonin Transporters.

Authors:  Su Bong Nam; Keunyoung Kim; Bum Soo Kim; Hyung-Jun Im; Seung Hun Lee; Seong-Jang Kim; In Joo Kim; Kyoungjune Pak
Journal:  Sci Rep       Date:  2018-03-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.